SHL make $2b revenue annually in the US. Decent but not huge.
They've staked a fair bit on the US as their primary growth opportunity so have been fairly aggressive in that market.
Seem to be having some success rolling out their Thyroseq novel genomic test in the US. Retails for about $2k and much smaller market. Don't know much else about it but hopefully they have enough experience to make this a success.
Ann: Proteomics signs binding LOI with Sonic Healthcare USA, page-11
-
- There are more pages in this discussion • 46 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.03 |
Change
0.005(0.49%) |
Mkt cap ! $134.2M | |||
| Open | High | Low | Value | Volume |
| $1.03 | $1.06 | $1.00 | $134.2K | 131.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3987 | $1.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.03 | 4762 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| PIQ (ASX) Chart |